#healthcare

📰News 📈 Stocks

Addus HomeCare Targets $280M Revenue Boost With $275M AccentCare Acquisition

September 23, 2026 (3 days ago)

Addus HomeCare leverages its strong balance sheet to fund a major $275 million acquisition, aiming to scale its personal care operations across…

ADUS

🌍 AMERICAS Read More →

📰News 📈 Stocks

Abbott and Intuitive Surgical Revenue Trends Show Divergent Growth Paths

September 23, 2026 (3 days ago)

Abbott Laboratories and Intuitive Surgical navigate distinct growth phases, with Abbott prioritizing stability and dividends while Intuitive maintains aggressive revenue expansion despite…

ISRG ABT

🌍 AMERICAS Read More →

📰News 📈 Stocks

Eli Lilly Shares Trail S&P 500 With 8% Gain, Marking Weakest Year Since 2016

September 23, 2026 (3 days ago)

Eli Lilly faces its most challenging year since 2016 as high valuations and rising competition in the GLP-1 sector pressure the stock,…

LLY

🌍 AMERICAS Read More →

📰News 📈 Stocks

Baxter Shares Slip 24% From Highs Amid Operational and Supply Chain Headwinds

September 23, 2026 (3 days ago)

Baxter International faces a bearish outlook as supply chain disruptions and margin compression weigh on performance, leaving the stock trailing the broader…

BAX BDX ^IXIC

🌍 AMERICAS Read More →

📊Earnings 📈 Stocks

Target Healthcare REIT Reports 12% Return as Earnings and Dividends Climb

September 22, 2026 (4 days ago)

Target Healthcare REIT posts strong annual results with a 7.6% increase in EPRA earnings per share and a dividend hike, supported by…

THRL

🌍 EUROPE Read More →

📰News 📈 Stocks

Healthpeak Properties Rallies 27% in 2026 on Strong FFO Guidance

September 21, 2026 (4 days ago)

Healthcare REIT Healthpeak Properties maintains a bullish outlook with a 6% monthly dividend and upwardly revised FFO guidance, even as rising interest…

DOC O

🌍 AMERICAS Read More →

🚀IPO 📈 Stocks

ADARx Targets $1.74 Billion Valuation in Upcoming Nasdaq IPO

September 21, 2026 (4 days ago)

ADARx Pharmaceuticals eyes a $1.74 billion valuation as it joins a wave of biotech listings, supported by a strategic $100 million investment…

ADRX ABBV Electra Therapeutics +1

🌍 US Read More →

📰News 📈 Stocks

The Ensign Group Shares Slip 3% Amid Short-Seller Allegations in Q2 2026

September 21, 2026 (5 days ago)

The Ensign Group (ENSG) shares faced volatility in Q2 2026 after short-seller reports alleged operational misconduct, though management's rebuttal helped the stock…

ENSG

🌍 US Read More →

📰News 📈 Stocks

Pfizer, Abbott, and Medtronic: 3 Healthcare Stocks for Long-Term Portfolios

September 20, 2026 (6 days ago)

Healthcare giants Pfizer, Abbott, and Medtronic offer investors a combination of reliable dividend growth and strategic innovation to navigate long-term market cycles.

PFE ABT MDT +2

🌍 AMERICAS Read More →

📰News 📈 Stocks

Thermo Fisher Rallies 8% as Biotech Funding Recovery Drives UBS Upgrade

September 20, 2026 (6 days ago)

Thermo Fisher gains momentum on strong organic growth and biotech recovery, while Becton Dickinson struggles with regulatory hurdles and higher short interest.

TMO BDX MDT +2

🌍 US Read More →

📰News 📈 Stocks

Waters Corp Shares Hit 52-Week High on 41% Annual Gains

September 19, 2026 (7 days ago)

Waters Corporation stock surges 41.5% over the past year, fueled by strong demand for chromatography and mass spectrometry systems, outpacing sector benchmarks…

WAT A XLV

🌍 AMERICAS Read More →

📰News 📈 Stocks

Biotech IPO Market Faces Scrutiny as 8 Firms Seek Capital for Clinical Trials

September 18, 2026 (7 days ago)

Investors are prioritizing clinical-stage biotechs with proven potential, as eight companies navigate the IPO process with varying degrees of market readiness and…

Grifols Electra Therapeutics Tarsier Therapeutics +6

🌍 GLOBAL Read More →